pyroglutamyl-histidyl-glycine has been researched along with dimethylhydrazines in 2 studies
Studies (pyroglutamyl-histidyl-glycine) | Trials (pyroglutamyl-histidyl-glycine) | Recent Studies (post-2010) (pyroglutamyl-histidyl-glycine) | Studies (dimethylhydrazines) | Trials (dimethylhydrazines) | Recent Studies (post-2010) (dimethylhydrazines) |
---|---|---|---|---|---|
42 | 0 | 7 | 1,400 | 4 | 78 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reichelt, KL; Skraastad, O | 1 |
Lachowicz, A; Pawlikowski, M; Stepień, H; Szadowska, A; Winczyk, K; Zerek-Mełeń, G | 1 |
2 other study(ies) available for pyroglutamyl-histidyl-glycine and dimethylhydrazines
Article | Year |
---|---|
An endogenous colon mitosis inhibitor reduces the increased cell proliferation in colonic epithelium induced by dietary cholic acid and treatment with 1,2-dimethylhydrazine.
Topics: 1,2-Dimethylhydrazine; Animals; Calcium; Cell Division; Cholic Acid; Cholic Acids; Colon; Diet; Dimethylhydrazines; Epithelial Cells; Epithelium; Growth Inhibitors; Intestinal Mucosa; Methylhydrazines; Mice; Mice, Mutant Strains; Mitosis; Oligopeptides; Pyrrolidonecarboxylic Acid | 1989 |
Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Topics: Adenocarcinoma; Adenoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dimethylhydrazines; Growth Inhibitors; Hyperplasia; Intestinal Mucosa; Male; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1993 |